Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure.

MLA

Karram, Tony, et al. “Effects of Spironolactone and Eprosartan on Cardiac Remodeling and Angiotensin-Converting Enzyme Isoforms in Rats with Experimental Heart Failure.” American Journal of Physiology: Heart & Circulatory Physiology, vol. 289, no. 4, Oct. 2005, pp. H1351–58. EBSCOhost, https://doi.org/10.1152/ajpheart.01186.2004.

APA

Karram, T., Abbasi, A., Keidar, S., Golomb, E., Hochberg, I., Winaver, J., Hoffman, A., & Abassi, Z. (2005). Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure. American Journal of Physiology: Heart & Circulatory Physiology, 289(4), H1351–H1358. https://doi.org/10.1152/ajpheart.01186.2004

Chicago

Karram, Tony, Anan Abbasi, Shiomo Keidar, Ehahu Golomb, Irit Hochberg, Joseph Winaver, Aaron Hoffman, and Zaid Abassi. 2005. “Effects of Spironolactone and Eprosartan on Cardiac Remodeling and Angiotensin-Converting Enzyme Isoforms in Rats with Experimental Heart Failure.” American Journal of Physiology: Heart & Circulatory Physiology 289 (4): H1351–58. doi:10.1152/ajpheart.01186.2004.